Aion Therapeutic Inc.
AION
CNSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 254.60K | 317.60K | 107.20K | 164.50K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 254.60K | 317.60K | 107.20K | 164.50K | -- |
| Cost of Revenue | 175.80K | 176.30K | 107.60K | 43.20K | -- |
| Gross Profit | 78.80K | 141.30K | -400.00 | 121.30K | -- |
| SG&A Expenses | 431.00K | 339.60K | 333.00K | 280.50K | 198.20K |
| Depreciation & Amortization | 20.90K | 20.90K | 20.00K | 11.10K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 627.70K | 536.90K | 460.60K | 334.70K | 198.20K |
| Operating Income | -373.10K | -219.30K | -353.40K | -170.30K | -198.20K |
| Income Before Tax | -426.80K | -270.80K | -3.98M | -279.90K | -133.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -426.80K | -270.80K | -3.98M | -279.90K | -133.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -426.80K | -270.80K | -3.98M | -279.90K | -133.60K |
| EBIT | -373.10K | -219.30K | -353.40K | -170.30K | -198.20K |
| EBITDA | -368.30K | -214.50K | -346.20K | -169.50K | -- |
| EPS Basic | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 484.01M | 452.31M | 406.77M | 315.90M | 190.32M |
| Average Diluted Shares Outstanding | 484.01M | 452.31M | 406.77M | 315.90M | 190.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
